Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial

Fractures are frequent in patients receiving hemodialysis. We tested the hypothesis that cinacalcet would reduce the rate of clinical fractures in patients receiving hemodialysis using data from the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events trial, a placebo-controlled trial...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Am Soc Nephrol
Autores principales: Moe, Sharon M., Abdalla, Safa, Chertow, Glenn M., Parfrey, Patrick S., Block, Geoffrey A., Correa-Rotter, Ricardo, Floege, Jürgen, Herzog, Charles A., London, Gerard M., Mahaffey, Kenneth W., Wheeler, David C., Dehmel, Bastian, Goodman, William G., Drüeke, Tilman B.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Nephrology 2015
Materias:
Clinical Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4446874/
https://ncbi.nlm.nih.gov/pubmed/25505257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014040414
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares